Charles K. Sholtz

Director and Associate General Counsel
Biosimilars, Manufacturing & Litigation Readiness Lead at Genentech (South San Francisco, CA)

Co-Chair’s Opening Remarks

June 24, 2019 8:00 am

Immac “Casey” Thampoe

Executive Director/Assistant General Counsel, IP Portfolio Development at Regeneron Pharmaceuticals, Inc. (Tarrytown, NY)

Co-Chair’s Opening Remarks

June 24, 2019 8:00 am


Jeffrey C. Bank

Partner at Wilson Sonsini Goodrich & Rosati (New York, NY)

Dr. David Blackburn

Managing Director and Head of NERA’s Life Sciences Industry Group at NERA Economic Consulting

The Honorable Jacqueline Bonilla

Deputy Chief Judge
Patent Trial and Appeal Board at U.S. Patent & Trademark Office

View from the Bench

June 25, 2019 9:45 am

Maureen Bresnahan

Assistant General Counsel at Eisai (Andover, MA)

Jonathan S. Caplan

Partner at Kramer Levin Naftalis & Frankel LLP

View from the Bench

June 25, 2019 9:45 am

David W. Clough

Senior Partner at Polsinelli PC (Chicago, IL)

Carol Pitzel Cruz

Partner at Knobbe Martens (Seattle, WA)

Jeffrey K. Francer

Senior Vice President & General Counsel at Association for Accessible Medicines (AAM) (Washington, DC)

Joseph Franklin

Associate Director for Policy, Therapeutic Biologics and Biosimilars Staff Office of New Drugs, CDER at U.S. Food & Drug Administration (Washington, DC)

Nicholas Groombridge

Partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP (New York, NY)

Jonathan A. Harris

Partner at Axinn Veltrop & Harkrider LLP (Hartford, CT)

Omar Jabri

Senior Director of Global Intellectual Property at Apotex Inc. (Toronto, CA)

Michael W. Johnson

Partner at Willkie Farr & Gallagher LLP (New York, NY)

David Korn

Vice President, Intellectual Property and Law at PhRMA (Washington, DC)

Steven D. Maslowski

Partner at Akin Gump Strauss Hauer & Feld LLP (Philadelphia, PA)

Brian McCormick

Vice President & Chief Regulatory Counsel at Teva Pharmaceuitcals (Horsham, PA)

Dr. Christine Meyer

Managing Director and Chair of NERA’s Global Intellectual Property Practice at NERA Economic Consulting

John J. Molenda

Partner at Steptoe & Johnson LLP (New York, NY)

Jason Murata

Partner at Axinn, Veltrop & Harkrider LLP (San Francisco, CA)

Matthew A. Pearson

Partner at Akin Gump Strauss Hauer & Feld LLP (Philadelphia, PA)

Julia Pike

Vice President of Intellectual Property, North America at Sandoz (Princeton, NJ)

Kevin S. Prussia

Partner at Wilmer Cutler Pickering Hale and Dorr LLP (Boston, MA)

Colman Ragan

VP & General Counsel
North America IP at Teva Pharmaceuticals

Tara Rahemba

Senior Director, Patent Counsel at Alexion Pharmaceuticals, Inc. (New Haven, CT)

Honorable Teresa Rea

Partner at Crowell & Moring LLP (Washington, DC) (Former Acting Under Secretary of Commerce for Intellectual Property and Former Acting Director of the United States Patent and Trademark Office)

Hans Sauer

Deputy General Counsel, VP for Intellectual Property at Biotechnology Innovation Organization (Washington, DC)

Petra Scamborova

Director, Dispute Resolution at Regeneron Pharmaceuticals, Inc.

Timothy Shea Jr.

Director at Sterne Kessler Goldstein & Fox, P.L.L.C. (Washington, DC)
Laura Sim

Laura Sim

Sr. Counsel
Development, Regulatory, Operations & Contracting Law at Amgen

Laura Storto

Assistant General Counsel, Associate Director at Genentech (South San Francisco, CA)

Jeanna M. Wacker

Partner at Kirkland & Ellis LLP(New York, NY)

Mark E. Waddell

Co-Chair, Life Sciences at Loeb & Loeb LLP (New York, NY)

Elizabeth S. Weiswasser

Partner at Weil, Gotshal & Manges LLP (New York, NY)

Lori Wolfe

Assoc. General Counsel, North America IP Litigation at Teva Pharmaceuticals

Timothy Worrall

Shareholder at Polsinelli PC (Denver, CO)